This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Jazz Pharma Still Making Investors Sing

Jazz passes my overall performance test however, and earns a current momentum grade A+.


Here is where valuation comes into play.

Data from Best Stocks Now App

I see a stock that is trading at 19 times forward earnings. Jazz is expected to continue to grow those earnings by about 19% per year over the next five years. That makes for a very reasonable price-to-earnings growth ratio of just 0.98.

When I do the math, I come up with a five-year target price of $300 on the stock. Jazz is currently only trading at $152. In other words, I see a stock that has 98% upside potential.

Will Jazz ever get there? I don't know. But if Jazz can continue to execute, I'll stay along for the ride.

Stock Chart

Lastly, I see a chart that's still hitting new highs. As far as I'm concerned, all systems are still go on Jazz.

Out of 3,813 stocks in my Best Stocks Now app database, Jazz comes in fifth. It's a stock that I own at Gunderson Capital Management in my aggressive portfolios accounts.

Data from Best Stocks Now App

At the time of publication, the author held JAZZ in his managed portfolios.

This article represents the opinion of a contributor and not necessarily that of TheStreet or its editorial staff.

2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
JAZZ $182.65 -0.19%
AAPL $130.35 -1.70%
FB $80.67 -1.50%
GOOG $553.67 -0.31%
TSLA $230.44 -0.48%


DOW 18,110.14 +72.17 0.40%
S&P 500 2,113.09 +4.17 0.20%
NASDAQ 5,050.0810 -10.1650 -0.20%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs